ARTICLE | Company News
Repligen board of directors update
July 7, 2008 7:00 AM UTC
Repligen Corp. (NASDAQ:RGEN), Waltham, Mass. Business: Neurology, Autoimmune, Gastrointestinal Appointed: Alfred Goldberg, professor of cell biology at Harvard Medical School ...